ID: ALA4581323

Max Phase: Preclinical

Molecular Formula: C27H31NO10

Molecular Weight: 529.54

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CC(=O)OCC(COC(C)=O)[C@@H]1C[C@H](OC(C)=O)[C@@]2(C)Oc3cc(-c4cccnc4)oc(=O)c3[C@@H](O)[C@@H]2C1

Standard InChI:  InChI=1S/C27H31NO10/c1-14(29)34-12-19(13-35-15(2)30)18-8-20-25(32)24-22(38-27(20,4)23(9-18)36-16(3)31)10-21(37-26(24)33)17-6-5-7-28-11-17/h5-7,10-11,18-20,23,25,32H,8-9,12-13H2,1-4H3/t18-,20-,23-,25-,27-/m0/s1

Standard InChI Key:  QSIIALBNMATAIA-SDIIZVJKSA-N

Associated Targets(Human)

Acyl coenzyme A:cholesterol acyltransferase 2 288 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 529.54Molecular Weight (Monoisotopic): 529.1948AlogP: 2.59#Rotatable Bonds: 7
Polar Surface Area: 151.46Molecular Species: NEUTRALHBA: 11HBD: 1
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.86CX Basic pKa: 4.21CX LogP: -0.20CX LogD: -0.20
Aromatic Rings: 2Heavy Atoms: 38QED Weighted: 0.42Np Likeness Score: 1.31

References

1.  (2016)  Class of tricyclic analogue, preparation method and use thereof, 

Source